AV
Ashwani Verma UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.2B
| $380.47 | $560 |
47%
upside
| Buy | yesterday |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.46B
| $14.99 | $20 |
33%
upside
| Buy | 15 days ago |
|
3
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $36 |
41%
upside
| Buy | 27 days ago |
|
4
Exelixis
EXEL
$10.1B
| $37.38 | $38 |
2%
upside
| Neutral | 1 month ago |
|
5
Immunovant
IMVT
$2.81B
| $16.12 | $18 |
12%
upside
| Neutral | 1 month ago |
|
6
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $174 |
24%
upside
| Buy | 1 month ago |
|
7
Legend Biotech
LEGN
$6.46B
| $34.99 | $54 |
54%
upside
| Buy | 2 months ago |
|
8
Teva Pharmaceuticals
TEVA
$21.2B
| $18.48 | $23 |
24%
upside
| Buy | 2 months ago |
|
9
Alkermes
ALKS
$4.77B
| $28.92 | $42 |
45%
upside
| Buy | 2 months ago |
|
10
Incyte
INCY
$16.7B
| $85.44 | $61 |
29%
downside
| Neutral | 3 months ago |
|
11
Cytokinetics
CYTK
$5.95B
| $49.75 | $41 |
18%
downside
| Neutral | 4 months ago |
|
12
Harmony Biosciences
HRMY
$2.09B
| $36.30 | $48 |
32%
upside
| Buy | 4 months ago |
|
13
Jazz Pharmaceuticals
JAZZ
$7.77B
| $128.02 | $179 |
40%
upside
| Buy | 6 months ago |
|
14
Arcellx
ACLX
$4B
| $72.16 | $114 |
58%
upside
| Buy | 8 months ago |
|
15
Biohaven
BHVN
$1.7B
| $16.07 | $54 |
236%
upside
| Buy | 1 year ago |
|
16
Axsome Therapeutics
AXSM
$6.21B
| $124.41 | $105 |
16%
downside
| Buy | 1 year ago |
|
17
Royalty Pharma
RPRX
$16B
| $36.90 | $28 |
24%
downside
| Neutral | 1 year ago |
|
18
Coherent
COHR
$14.9B
| $95.62 | $7 |
93%
downside
| Buy | 2 years ago |
|
19
Viatris
VTRS
$12B
| $10.33 | $12 |
16%
upside
| Neutral | 2 years ago |
|